1. Home
  2. ALT vs USBC Comparison

ALT vs USBC Comparison

Compare ALT & USBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALT
  • USBC
  • Stock Information
  • Founded
  • ALT 1997
  • USBC N/A
  • Country
  • ALT United States
  • USBC
  • Employees
  • ALT N/A
  • USBC 6
  • Industry
  • ALT Biotechnology: Pharmaceutical Preparations
  • USBC
  • Sector
  • ALT Health Care
  • USBC
  • Exchange
  • ALT Nasdaq
  • USBC Nasdaq
  • Market Cap
  • ALT 348.6M
  • USBC 317.2M
  • IPO Year
  • ALT N/A
  • USBC N/A
  • Fundamental
  • Price
  • ALT $4.05
  • USBC $0.98
  • Analyst Decision
  • ALT Strong Buy
  • USBC
  • Analyst Count
  • ALT 7
  • USBC 0
  • Target Price
  • ALT $16.50
  • USBC N/A
  • AVG Volume (30 Days)
  • ALT 2.8M
  • USBC N/A
  • Earning Date
  • ALT 11-06-2025
  • USBC N/A
  • Dividend Yield
  • ALT N/A
  • USBC N/A
  • EPS Growth
  • ALT N/A
  • USBC N/A
  • EPS
  • ALT N/A
  • USBC N/A
  • Revenue
  • ALT $20,000.00
  • USBC N/A
  • Revenue This Year
  • ALT N/A
  • USBC N/A
  • Revenue Next Year
  • ALT N/A
  • USBC N/A
  • P/E Ratio
  • ALT N/A
  • USBC N/A
  • Revenue Growth
  • ALT N/A
  • USBC N/A
  • 52 Week Low
  • ALT $2.90
  • USBC N/A
  • 52 Week High
  • ALT $11.16
  • USBC N/A
  • Technical
  • Relative Strength Index (RSI)
  • ALT 54.55
  • USBC 48.61
  • Support Level
  • ALT $3.93
  • USBC $0.93
  • Resistance Level
  • ALT $4.25
  • USBC $1.06
  • Average True Range (ATR)
  • ALT 0.18
  • USBC 0.12
  • MACD
  • ALT 0.00
  • USBC 0.02
  • Stochastic Oscillator
  • ALT 56.99
  • USBC 40.53

About ALT Altimmune Inc.

Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

About USBC USBC Inc. Common Stock

USBC Inc is a non-invasive medical diagnostics. The group is focused on the development and commercialization of proprietary sensor technology utilizing radio and microwave dielectric spectroscopy. Its Sensor technology elicits a dielectric response that is different for every molecule. The group considers the business to currently have one operating segment: the development of its radio frequency spectroscopy technology, with a first focus on non-invasively ascertaining blood glucose levels.

Share on Social Networks: